Dechra Pharmaceuticals (DPH) Insider Trading & Ownership GBX 3,866 0.00 (0.00%) (As of 01/16/2024) Add Compare Share Share Insider Trades Stock AnalysisDividendInsider Trades Dechra Pharmaceuticals (LON:DPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.29%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£5,017.35Number OfInsiders Selling(Last 12 Months)0 Get DPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Dechra Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DPH Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Dechra Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/15/2024Ian PageInsiderBuy155GBX 3,237£5,017.35 (Data available from 1/1/2013 forward) DPH Insider Trading Activity - Frequently Asked Questions Who is on Dechra Pharmaceuticals's Insider Roster? The list of insiders at Dechra Pharmaceuticals includes Alison Platt, Ian Page, John Shipsey, Lisa Bright, and Paul Sandland. Learn more on insiders at DPH. What percentage of Dechra Pharmaceuticals stock is owned by insiders? 9.29% of Dechra Pharmaceuticals stock is owned by insiders. Learn more on DPH's insider holdings. Which Dechra Pharmaceuticals insiders have been buying company stock? The following insider purchased DPH shares in the last 24 months: Ian Page (£5,017.35). How much insider buying is happening at Dechra Pharmaceuticals? Insiders have purchased a total of 155 DPH shares in the last 24 months for a total of £5,017.35 bought. Dechra Pharmaceuticals Key ExecutivesMr. Ian D. Page (Age 63)CEO, MD & Executive Director Compensation: $848kMr. Paul Nicholas Sandland MAAT (Age 45)FCCA, CFO & Executive Director Compensation: $559kMr. Patrick MeeusChief Scientific OfficerMr. Jamie AdamsChief Information OfficerMs. Katy CloughChief People OfficerMr. Mike Eldred (Age 54)President of North America Ms. Melanie Jane HallCompany Secretary More Insider Trading Tools from MarketBeat Related Companies DPLM Insider Buying HWDN Insider Buying IGG Insider Buying CTY Insider Buying SMWH Insider Buying GNS Insider Buying CAR Insider Buying STG Insider Buying CPG Insider Buying GSK Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:DPH) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dechra Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Dechra Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DPH Stock Alerts